Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma
NCT ID: NCT01606605
Last Updated: 2013-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
350 participants
OBSERVATIONAL
2011-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735
Gene Abnormalities and Prognosis in Diffuse Large B-cell Lymphoma
NCT04825899
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
NCT02141152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Diffuse large B-cell lymphoma patients
* Paraffin-embedded tissue
* End points: Progression-free survival, overall survival
* Statistics: Leave one-out method
2. Nano string assay for microRNA
* Diffuse large B-cell lymphoma patients
* Paraffin-embedded tissue
* End points: Progression-free survival, overall survival
* Statistics: Leave one-out method
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diffuse large B-cell lymphoma
Patients diagnosed and treated at the Samsung Medical Center
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with tissue blocks available for study
* Patients with adequate medical records
Exclusion Criteria
15 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Won Seog Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Won Seog Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center Cancer Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Cancer Research Institute
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-05-025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.